机译:术前全身免疫炎症指数和高敏感性改良甲虫治疗软组织Sarcoma术后术前的全身免疫炎症指数及高敏感性改良糖尿病的预后作用
Cent South Univ Xiangya Hosp 2 Dept Oncol Changsha Peoples R China;
Collaborat Innovat Ctr Canc Med State Key Lab Oncol South China Guangzhou Peoples R China;
Collaborat Innovat Ctr Canc Med State Key Lab Oncol South China Guangzhou Peoples R China;
Collaborat Innovat Ctr Canc Med State Key Lab Oncol South China Guangzhou Peoples R China;
Collaborat Innovat Ctr Canc Med State Key Lab Oncol South China Guangzhou Peoples R China;
Collaborat Innovat Ctr Canc Med State Key Lab Oncol South China Guangzhou Peoples R China;
Collaborat Innovat Ctr Canc Med State Key Lab Oncol South China Guangzhou Peoples R China;
Soft tissue sarcoma; SII; Hs-mGPS; Prognostic factors; Survival;
机译:修饰的Glasgow骨骼和软组织肉瘤患者的预后评分
机译:修饰的Glasgow骨骼和软组织肉瘤患者的预后评分
机译:自由基肾脏表切除术治疗患有大型尿路上皮癌(UTUC)患者的全身炎症改性Glasgow预后评分的预后价值:大型多中心国际合作的结果
机译:软组织肉瘤手术的计算机增强术前计划
机译:评估右心室功能对评估慢性血栓栓塞性肺动脉高压患者预后的作用
机译:Glasgow预后评分是胃癌患者长期存活的更好预测因素而改良的Glasgow预后评分或高敏感性改性Glasgow预后得分相比
机译:术前全身免疫炎症指数的预后作用和高敏感性改良的Glasgow在软组织Sarcoma自由基操作后患者预后评分